Published in Mol Vis on August 08, 2002
Genetic evidence for shared mechanisms of epimorphic regeneration in zebrafish. Proc Natl Acad Sci U S A (2009) 1.72
Neurogenesis in the fish retina. Int Rev Cytol (2007) 1.30
Müller glia: Stem cells for generation and regeneration of retinal neurons in teleost fish. Prog Retin Eye Res (2014) 1.30
Ontogeny of cone photoreceptor mosaics in zebrafish. J Comp Neurol (2010) 1.10
Have we achieved a unified model of photoreceptor cell fate specification in vertebrates? Brain Res (2007) 1.00
Targeted effects of retinoic acid signaling upon photoreceptor development in zebrafish. Dev Biol (2005) 0.99
Coupling mechanical deformations and planar cell polarity to create regular patterns in the zebrafish retina. PLoS Comput Biol (2012) 0.93
Regeneration of cone photoreceptors when cell ablation is primarily restricted to a particular cone subtype. PLoS One (2013) 0.93
The rod photoreceptor lineage of teleost fish. Prog Retin Eye Res (2011) 0.92
Design principles and developmental mechanisms underlying retinal mosaics. Biol Rev Camb Philos Soc (2014) 0.92
Neurogenin1 effectively reprograms cultured chick retinal pigment epithelial cells to differentiate toward photoreceptors. J Comp Neurol (2010) 0.90
Retinal regeneration is facilitated by the presence of surviving neurons. Dev Neurobiol (2014) 0.88
Exploring RPE as a source of photoreceptors: differentiation and integration of transdifferentiating cells grafted into embryonic chick eyes. Invest Ophthalmol Vis Sci (2006) 0.88
Reprogramming progeny cells of embryonic RPE to produce photoreceptors: development of advanced photoreceptor traits under the induction of neuroD. Invest Ophthalmol Vis Sci (2008) 0.88
Age-related cone abnormalities in zebrafish with genetic lesions in sonic hedgehog. Invest Ophthalmol Vis Sci (2008) 0.87
Plasticity of photoreceptor-generating retinal progenitors revealed by prolonged retinoic acid exposure. BMC Dev Biol (2011) 0.86
Patterning the cone mosaic array in zebrafish retina requires specification of ultraviolet-sensitive cones. PLoS One (2014) 0.83
Retinoic Acid Signaling Regulates Differential Expression of the Tandemly-Duplicated Long Wavelength-Sensitive Cone Opsin Genes in Zebrafish. PLoS Genet (2015) 0.80
rhomboid mediates specification of blue- and green-sensitive R8 photoreceptor cells in Drosophila. J Neurosci (2009) 0.76
Investigation of Adaptive Optics Imaging Biomarkers for Detecting Pathological Changes of the Cone Mosaic in Patients with Type 1 Diabetes Mellitus. PLoS One (2016) 0.76
Correlation between photoreceptor injury-regeneration and behavior in a zebrafish model. Neural Regen Res (2017) 0.75
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst (2005) 5.55
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol (2008) 3.40
Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression. J Pathol (2012) 2.07
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601). Lancet Oncol (2010) 2.01
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. J Clin Oncol (2007) 1.93
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial. J Clin Oncol (2008) 1.89
Responses of Müller glia to retinal injury in adult zebrafish. Vision Res (2004) 1.85
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial. Lancet Oncol (2011) 1.85
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. J Clin Oncol (2008) 1.75
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res (2010) 1.65
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
The p160 ER co-regulators predict outcome in ER negative breast cancer. Breast Cancer Res Treat (2011) 1.47
Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab (2011) 1.45
Clinicians' assessments of practice guidelines in oncology: the CAPGO survey. Int J Technol Assess Health Care (2004) 1.26
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. Breast Cancer Res (2010) 1.22
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer. Oncologist (2011) 1.21
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. Endocr Relat Cancer (2006) 1.21
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. J Clin Oncol (2005) 1.15
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer. Clin Cancer Res (2007) 1.12
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol (2007) 1.11
Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-up. Histopathology (2009) 1.06
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer. Breast Cancer Res Treat (2011) 1.02
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling. Mol Cancer Ther (2007) 0.99
Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis. J Clin Oncol (2008) 0.99
Targeted effects of retinoic acid signaling upon photoreceptor development in zebrafish. Dev Biol (2005) 0.99
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer (2013) 0.97
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast Cancer Res Treat (2006) 0.96
Cellular correlates of proneural and Notch-delta gene expression in the regenerating zebrafish retina. Vis Neurosci (2007) 0.93
Current perspective - trastuzumab. Eur J Cancer (2008) 0.92
Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance. Mol Endocrinol (2007) 0.91
Control of cellular pattern formation in the vertebrate inner retina by homotypic regulation of cell-fate decisions. J Neurosci (2005) 0.91
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. Eur J Cancer (2012) 0.88
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells. Carcinogenesis (2005) 0.88
Age-related cone abnormalities in zebrafish with genetic lesions in sonic hedgehog. Invest Ophthalmol Vis Sci (2008) 0.87
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases. Clin Breast Cancer (2009) 0.87
Photoreceptor differentiation during retinal development, growth, and regeneration in a metamorphic vertebrate. J Neurosci (2004) 0.86
Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy. Mol Vis (2010) 0.86
Plasticity of photoreceptor-generating retinal progenitors revealed by prolonged retinoic acid exposure. BMC Dev Biol (2011) 0.86
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence. Pharmacoeconomics (2011) 0.85
Health economics in drug development: efficient research to inform healthcare funding decisions. Eur J Cancer (2010) 0.85
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. J Clin Oncol (2005) 0.85
Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer. Breast Cancer Res Treat (2013) 0.84
Layer 6 cortical neurons require Reelin-Dab1 signaling for cellular orientation, Golgi deployment, and directed neurite growth into the marginal zone. Neural Dev (2012) 0.83
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. Breast Cancer Res Treat (2010) 0.82
Effects of induced systemic hypothyroidism upon the retina: regulation of thyroid hormone receptor alpha and photoreceptor production. Mol Vis (2006) 0.82
Assessment of the effect of chemotherapy on ovarian function in women with breast cancer. J Clin Oncol (2007) 0.80
Advancing cancer drug discovery towards more agile development of targeted combination therapies. Future Med Chem (2012) 0.80
Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. Int J Radiat Oncol Biol Phys (2011) 0.80
Beware using secular trends in deaths to judge effectiveness of breast screening. BMJ (2013) 0.78
Light responses in rods of vitamin A-deprived Xenopus. Invest Ophthalmol Vis Sci (2009) 0.77
An economic evaluation of docetaxel and paclitaxel regimens in metastatic breast cancer in the UK. Pharmacoeconomics (2009) 0.76
Pertuzumab for the treatment of metastatic breast cancer. Expert Rev Anticancer Ther (2013) 0.76
Lapatinib for inflammatory breast cancer. Lancet Oncol (2009) 0.76
Chemotherapy, trastuzumab, and pathological complete response: when shall we three meet again? J Clin Oncol (2011) 0.75
Authors' reply. J Pathol (2013) 0.75
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? Breast Cancer Res (2013) 0.75
The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients. Eur J Cancer (2008) 0.75
Cellular pattern formation during retinal regeneration: a role for homotypic control of cell fate acquisition. Vision Res (2006) 0.75
Expression of activated type I receptor tyrosine kinases in early breast cancer. Breast Cancer Res Treat (2012) 0.75